CAH vs SOLV: fair value comparison
Cardinal Health, Inc. and Solventum Corporation · Updated 2026-08-31
CAH currently screens as overvalued while SOLV screens as fairly valued. Within Healthcare, SOLV currently sits closer to the top of our discount ranking.
| CAH | SOLV | |
|---|---|---|
| Verdict | Overvalued | Fairly valued |
| Last price | $234.55 | $91.12 |
| 12-month range | $149.55–$235.60 | $64.35–$88.07 |
| Sector rank | #92 of 113 Healthcare | #87 of 113 Healthcare |
| Quality grade | F | F |
| Momentum grade | A | A |
| Leverage | Low | High |
| Margin trend | Stable | Contracting |
| Revenue growth | Modest | Modest |
| RSI zone | Neutral | Neutral |
| DCF cross-check | Overvalued | — |
| 52-week position | The top quarter | The top quarter |
Full single-stock breakdowns: CAH fair value analysis · SOLV fair value analysis